Transaktionen anzeigen
Private Equity | Gesundheitswesen

The MOLE Clinic Limited has been acquired by Sk:n (backed by TriSpan)

The shareholders of The MOLE Clinic Limited have sold the company to Sk:n.

The MOLE Clinic is a leading independent provider of skin cancer screening, diagnosis and treatment services to private patients and to the NHS. It screens over 30,000 patients annually using advanced diagnostic techniques from five London clinics, including on Harley Street, Oxford Circus and Moorgate, as well as via its award-winning tele-dermatology offering to GPs nationally.

Sk:n is the largest network of specialist skin care clinics in the UK and is backed by Trispan, a specialist private equity firm. This acquisition further strengthens Sk:n’s skin cancer screening offering and adds to its growing range of skin care services. As part of integrating the business into the Group, they plan to roll out The MOLE Clinic’s offering across the Sk:n clinic network nationally.

Demand for The MOLE Clinic’s services has been growing and the shareholders were looking for a strategic partner to help support their expansion. Oaklins Smith & Williamson, based in the UK, worked with the The MOLE Clinic’s shareholders to deliver a successful sale to a strategic partner that is able to expand the clinic network and help support the business through its next phase of growth.

DIENSTLEISTUNG
Verkauf
PARTEIEN
«I found the advice and hands-on support provided by the Oaklins Smith & Williamson team to be invaluable and a significant factor in achieving a successful transaction. Their understanding of the medical and healthcare sector as well as a focus on owner-managed businesses proved vital in not just solving problems but anticipating and addressing them before they arose. I cannot recommend their team highly enough.»

Iain Mack

Founder and Managing Director, The MOLE Clinic

Sprechen Sie mit dem Deal Team

 Brian  Livingston

Brian Livingston

Managing Director

London, Grossbritannien
Oaklins Smith & Williamson
 Stuart  Goodman

Stuart Goodman

Director

London, Grossbritannien
Oaklins Smith & Williamson
 Joe  Sherry

Joe Sherry

Associate

London, Grossbritannien
Oaklins Smith & Williamson

Transaktionen

Permali Gloucester has been acquired by Diamorph (subject to regulatory approval)
Private Equity | Luft- und Raumfahrt | Automobilindustrie | Maschinen- & Anlagenbau, Komponenten

Permali Gloucester has been acquired by Diamorph (subject to regulatory approval)

Private equity firm 3i Group and the private shareholders of Permali Gloucester Limited have sold their interest in the company to Diamorph.

Mehr erfahren
BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher
Private Equity | Andere Branchen

BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher

BaltCap Lithuania SME Fund has sold its 46% shareholding in Labochema UAB, a Lithuanian laboratory supplies trading company, to Dominique Dutscher. Labochema’s CEO and the chairman also sold their shareholdings. As a result of the transaction, Dominique Dutscher now controls 100% of Labochema.

Mehr erfahren
Paaschburg & Wunderlich GmbH has been acquired by Bihr N.V.
Private Equity | Handel

Paaschburg & Wunderlich GmbH has been acquired by Bihr N.V.

The shareholders of Paaschburg & Wunderlich GmbH (P&W) have sold 100% of their shares to Bihr N.V.

Mehr erfahren